Due to the potential role of CYP4B1 in fatty acid metabolism, the study will help to explore the molecular mechanism of the occurrence and development of lung cancer and then lay a theoretical foundation for targeted metabolic reprogramming to treat lung cancer. This evidence concerns the gene CYP4B1 and lung carcinoma.